Skip to main content
logo
NervGen Pharma Corp. (TSXV:NGEN)
Canada flag Canada · Delayed Price · Currency is CAD
5.15
+0.15 (3.00%)
Inactive · Last trade price on Mar 16, 2026

NervGen Pharma Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
4102211619412478
Market Cap Growth
110.05%37.18%71.42%-24.19%58.14%36.12%
Enterprise Value
3992001466611671
Last Close Price
5.153.142.701.602.732.23

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
-139.4485.68-80.106.987.3613.23
P/TBV Ratio
-104.55-7.217.5814.37

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.010.04-0.100.02--
Net Debt / Equity Ratio
3.85-6.665.71-1.65-1.01-0.95
Net Debt / EBITDA Ratio
0.450.690.650.971.330.50
Net Debt / FCF Ratio
0.681.021.011.252.050.89
Quick Ratio
0.731.050.792.2015.767.50
Current Ratio
0.791.130.832.2716.168.21
Return on Equity (ROE)
-820.11%-8460.20%-390.89%-136.87%-111.94%-190.21%
Return on Assets (ROA)
-88.77%-95.24%-59.88%-68.90%-65.17%-104.12%
Return on Capital Employed (ROCE)
857.90%-964.50%933.90%-168.60%-76.20%-189.10%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-6.23%-10.87%-13.91%-22.07%-10.28%-14.28%
FCF Yield
--7.63%-7.02%-18.96%-6.68%-8.05%
Buyback Yield / Dilution
-10.41%-13.55%-12.61%-34.00%-22.35%-23.97%